Multiscale biophysical models of cardiomyopathies reveal complexities challenging existing dogmas

Brent Scott1, Michael J Greenberg1

  • 1Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri.

Biophysical Journal
|November 25, 2023
PubMed

Insights

Myosin mutations cause cardiomyopathies, but the link between motor function and disease type is complex. Recent studies challenge the simple hypercontractility/hypertrophic and hypocontractility/dilated cardiomyopathy hypothesis, emphasizing multiscale modeling.

Area of Science:

  • Cardiovascular Research
  • Biophysics
  • Molecular Medicine

Background:

  • Mutations in sarcomeric proteins, particularly myosin, are linked to various cardiomyopathies.
  • A prevailing hypothesis suggested myosin mutations causing hypercontractility lead to hypertrophic cardiomyopathy, while hypocontractility causes dilated cardiomyopathy.

Discussion:

  • Recent biophysical studies using multiscale computational and experimental models reveal complexities beyond the simple hypercontractility/hypocontractility hypothesis.
  • These findings challenge the established dogma regarding myosin mutation effects in cardiomyopathies.

Key Insights:

  • The relationship between myosin motor function and specific cardiomyopathy subtypes (hypertrophic vs. dilated) is more intricate than previously assumed.
  • Simple models of contractility are insufficient to explain the diverse clinical presentations of myosin-related cardiomyopathies.

Outlook:

  • There is a growing need for advanced multiscale modeling approaches to fully understand the pathogenesis of these complex cardiac diseases.
  • Future research should integrate biophysical data with clinical observations to refine our understanding of sarcomeric proteinopathies.

Related Concept Videos